
Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, ALS, and Huntington’s Disease, are on the rise worldwide. Yet, there are no effective therapies to cure, prevent, or treat most of these disorders.
To make progress, we launched the Neurodegeneration Challenge Network (NDCN) — bringing together experimental scientists from diverse research fields, along with computational biologists and physicians, to look at this problem across diseases.
Read how this effort is taking shape through the story of Rebecca and Elizabeth — a pair of NDCN researchers working together to treat and prevent rare neurodegenerative diseases that impact children.
Learn more about how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
Keep Reading
Back to allObsessed with the nucleus
CZ Biohub San Francisco Investigator Hawa Racine Thiam’s new Stanford lab applies physics to the study of cells and their nuclei
Learn More
Building devices that unite cells and sensors
Csaba Forró, a Chicago Biohub group leader, discusses how merging physics, engineering, and biology helps researchers investigate disease at the cellular...
Learn More
Everything everywhere all at once: ‘Zebrahub’ tracks development like never before
A ‘Google Earth’ of embryology, CZ Biohub San Francisco's zebrafish cell atlas brings a new vision to developmental biology
Learn More
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.